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TNFa GENE TARGETING VIA TRIPLE-HELIX FORMATION: COULD AN
ANTI-GENE STRATEGY BE AN ALTERNATIVE TO ANTI TNF ANTIBODIES
FOR ARTHRITIS?
L. Grossin, Jr., J. Paquet, Jr., C. Henrionnet, Jr., A. Pinzano, Jr., D. Loeuille,
Sr., P. Netter, Sr., P. Gillet, Sr.. UMR7561 CNRS, Vandoeuvre les nancy, France
Purpose:We investigated if an anti-TNF-a triplex-forming oligonucleotide
(TFO), employed as anti-gene strategy, could be an alternative to antisense
technology in silencing TNF-a activation during articular inﬂammation. In
this study, we analyzed in vitro and in vivo anti-inﬂammatory potentiali-
ties of an anti-TNF-a TFO, as judged from effects on two rat arthritis
models.
Methods: The inhibitory activity of this TFO on articular cells stimulated by
IL-1ß (synoviocytes and chondrocytes) was assessed and compared to that
of small interfering RNA (siRNA) in vitro, at mRNA expression levels by
real-time RT-PCR, as well as at proteins level (TNF-a & NO release). In vivo,
the biological effects of a preventive intraarticular injection of such an
oligonucleotide were ﬁrst investigated in an acute arthritis model, by the
follow-up of clinical (body weight, pain, joint swelling), biochemical
(anabolism loss, cytokines levels) and histological (synovium, cartilage,and
bone) parameters. We then conﬁrmed the efﬁciency of a preventive ia
injection of anti-TNF-a TFO in an immunological experimental chronic
arthritis model, according to similar parameters (clinical, biochemical and
histological assessments).
Results: In vitro, we have demonstrated that a TFO designed to target
TNF-a promoter was able to inhibit mRNA expression (86%) and to prevent
TNF-a release into supernatants (62%) as well as NO release (80%). The
inhibition rate, at mRNA level, was similar to the one observed with TNF-
a speciﬁc siRNA, the main advantage of TFO being the concentration used
(1nM vs 75 nM for siRNA). A differencewas observed at proteins level, with
approximatively a 20% more efﬁcient inhibition with TFO, compared to
siRNA.
The use of the anti-TNF-a TFO as a preventive and local treatment in both
acute and chronic arthritis models signiﬁcantly reduced diseasedevelopment. In the acute inﬂammatory model, the TFO provided
a stronger inhibition than the siRNA, with a long lasting biological effect,
conﬁrmed by histological assessement. In the immunological RA model,
we have demonstrated that a preventive ia injection of the TFO lead to
a signiﬁcant correction of body weight distribution (incapacitancy test),
conﬁrmed by the histological grading of the knees. Indeed, ﬁbrosis and
inﬁltration were signiﬁcantly decreased compraed to arthritic rats. Anal-
ysis of synovial ﬂuid has demonstrated a signiﬁcant decrease of inﬂam-
matory mediators like cytokines (TNF-a, IL-1ß, IL-2, IL-5) and chemokines
(MCP1, MIP-1a) in animals preventively treated with TFO compared to
naives. Furthermore, the TFO efﬁciently blocked synovitis and cartilage
and bone destruction in the joints.
Conclusions: We showed the effectiveness of siRNA and TFO in modu-
lating both in vitro and in vivo inﬂammatory processes. Interestingly,
silencing was increased with TFO, enabling improved protection of artic-
ular components. We extended our ﬁndings by demonstrating for the ﬁrst
time that in rats developing arthritis, a preventive injection of anti-TNF-
aTFO led to local and systemic TNF-a inhibition associated with
improvement of ancillary clinical signs of arthritis. The results presented
here provide the ﬁrst evidence that gene targeting by anti-TNF-a TFO
modulates arthritis in vivo, thus providing proof-of-concept that it could
be used as therapeutic tool for TNF-a-dependent inﬂammatory disorders.
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SUSTAINED REGULATION OF INFLAMMATION IN CHONDROCYTES BY
BIOMECHANICAL SIGNALS VIA THE JAK3-STAT3 PATHWAY
J. Nam1, P. Perera 2, B. Rath 3, S. Agarwal 2. 1Univ. of California, Riverside, CA,
USA; 2 The Ohio State Univ., Columbus, OH, USA; 3Univ. of Aachen, Aachen,
Germany
Purpose: Exercise is essential for maintaining cartilage health and thera-
peutic for degenerating cartilage during the progression of early osteoar-
thritis (OA) as shown in our animal models. At themolecular level, we have
also shown that physiological magnitudes of mechanical forces are anti-
inﬂammatory and suppress the transcriptional activities of nuclear tran-
scription factor kappaB (NF-kB) by intercepting NF-kB signaling cascades.
In this study, we examined the role of IL-11 via JAK3-STAT3-SOCS3
signaling cascade in inducing sustained anti-inﬂammatory state by phys-
iological magnitudes of dynamic compressive strain (DCS). These ﬁndings
further correlate with the attenuation of pro-inﬂammatory genes during
the progression of OA by exercise in an animal model.
Methods: OSU Institutional Animal and Care Committee preapproved all
protocols. Rat chondrocytes (5 x 105 cells/scaffold) were inoculated on 3D
6x3 mm cylindrical scaffolds fabricated by electrospinning of poly(ε-cap-
rolactone), 6 days prior to experimentation. Subsequently, the constructs
were subjected to various conditions: 1) untreated control, 2) IL-1b (1 ng/
ml), 3) DCS alone (10% cyclic strain at 1 Hz), or 4) IL-1b and DCS for various
durations. The effects of DCS on the overall gene expressionwere analyzed
by Affymetrix Rat GeneChip 1.0 ST microarrays and the results conﬁrmed
by real time PCR using custom designed primers for IL-11 and SOCS3.
Activation of the JAK-STAT pathway was examined via phosphorylation of
JAK1, -2, -3, and phosphorylation of STAT3, -5, and IL-11 protein expression
by Western blot analysis (WBA). To investigate the relationship between
IL-11 and JAK-STAT activation, IL-11 was knocked down by siRNA. All
experiments were performed at least in triplicate and statistical signiﬁ-
cance calculated by ANOVA with Tukey's post-hoc. Results: Microarray
gene expression analysis on the ACs subjected to IL-1b (1 ng/ml) alone or
10% DCS in the presence of IL-1b revealed that 1163 genes out of approx-
imately 27000 genes (detectable by GeneChip) were signiﬁcantly regu-
lated more than 2 fold as compared to untreated controls. Speciﬁcally,
most of the genes that were upregulated by IL-1b and drastically down-
regulated by DCS, were related to inﬂammation including Ccl20, Nos2a,
Cxcl2, Ccl7, Cx3cl1, Tnf, Cxcl6, Lcn2, Il23a, and Tnfaip2, known to be under
the control of the NF-kB pathway. On the other hand, IL-11 and its tran-
scriptional regulators (Fosb, Fos, Jun, Jund, and Atf3) were signiﬁcantly
upregulated by DCS in the presence of IL-1b. The WBA revealed that JAK3
and STAT3 are activated by DCS regardless of the presence of IL-1b. The
interference of DCS-induced IL-11 synthesis by IL-11 siRNA resulted in the
inhibition of STAT3 activation, likely indicating that DCS induces the JAK3-
STAT3 phosphorylation via IL-11 induction. The activation of STAT3, in
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cascade. The upregulation of SOCS3 may be responsible for the sustained
anti-inﬂammatory effects of DCS. This was also evident by the down-
regulation of pro-inﬂammatory and matrix-proteinase genes by micro-
array analysis of the chondrocytes subjected to 1) transient DCS over an
extended time period in vitro and 2) exercise during the early stages of the
progression of OA in rat knees.
Conclusions: The data suggest that dynamic biomechanical signals
attenuate inﬂammation in chondrocytes not only by inhibiting the acti-
vation of NF-kB, but also by suppressing the NF-kB activity through the
activation of SOCS3 via IL-11-mediated JAK3-STAT3 signaling. These
observations further underscore the mechanisms of short and gentle DCS
or exercise regimens in exerting sustained anti-inﬂammatory effects in
vitro and in vivo.464
ASSOCIATION OF ATHEROSCLEROSIS WITH PRESENCE AND
PROGRESSION OF OSTEOARTHRITIS OF THE KNEE AND HAND: THE
ROTTERDAM STUDY
T.A. Hoeven, M. Kavousi, S. Clockaerts, H.J. Kerkhof, J.B. van Meurs,
O.H. Franco, A. Hofman, P. Bindels, J.C. Witteman, S.M. Bierma-
Zeinstra. Erasmus Univ. Med. Ctr., Rotterdam, Netherlands
Purpose: Atherosclerosis is an important feature of cardio-metabolic
disorders and although some studies have indicated that atherosclerosis is
associated with osteoarthritis (OA), they are few in number, often lack
sufﬁcient power and are cross-sectional only. Hence, it is unclear whether
atherosclerosis and OA are associated, either as concurrent diseases due to
a common aetiology or causally related. We examined whether vascular
alterations are associated with the presence, incidence and progression of
OA of the knee, the hip, and the different hand joints in a large prospective
cohort study.
Methods: The study comprised 5,650 participants, aged 55 years and
older, from the population-based Rotterdam Study. Based on previous
literature, data was analyzed for men (n¼2,372) and women (n¼3,278)
separately. We scored X-rays of the knee, hip and hand using the Kellgren
& Lawrence (K&L) score for OA at baseline, after a mean follow-up of 6.6
years and 10 years. Measures of atherosclerosis (carotid intima media
thickness (IMT) and presence of carotid plaque) and data on covariates
(age, body mass index, diabetes, hypertension, total cholesterol/HDL and
smoking) were collected at baseline. A multivariate logistic regression
model with generalized estimated equations was used to analyze the
association between measures of atherosclerosis and the presence and
overall progression (incidence and progression combined) of OA of the
hand, knee and hip joints. In the multivariate analyses on overall
progression of OA, we adjusted for follow-up time and K&L score at
baseline next to the other covariates. Crude and adjusted odds ratios with
95% conﬁdence intervals were calculated.
Results: In women, signiﬁcant associations between measures of athero-
sclerosis and prevalence of knee OA and hand OA were found; carotid
intima media thickness (IMT) with knee OA (adjusted odds ratio (aOR) 1.7
(1.1 - 2.7)), carotid plaquewith distal interphalangeal (DIP) OA (aOR 1.4 (1.2
- 1.7)) and with metacarpophalangeal (MCP) OA (aOR 1.5 (1.1 - 2.2)). No
associations were found for hip OA. Results from prevalence of MCP OA
were conﬁrmed in overall progression of MCP OA in women; carotid
intima media thickness (IMT) with overall progression of MCP OA (aOR 2.9
(1.2 - 6.9)). Results from prevalence of knee OA in women tended toward
conﬁrmation in overall progression of knee OA, but were only borderline
signiﬁcant. However, for overall progression of hip OA in women, odds
ratios tended toward a protective effect. In men, no signiﬁcant associations
were found.
Conclusions: In the present study we found an association between
atherosclerosis and OA of the knee, MCP and DIP joints in women. Our
results indicate that in women atherosclerosis and OA of the knee and
hand are at least concurrent diseases that share risk factors and there
might be a role for atherosclerosis in the progression of the disease as well.
Further studies are required to clarify the nature of the association found
and the joint differences identiﬁed.465
IMPLICATION OF CIRCULATING NATURAL ANTIBODIES AGAINST
ANGIOTENSIN-CONVERTING ENZYME IN THE PERIPHERAL BLOOD
SERA OF PATIENTS WITH KNEE OSTEOARTHRITIS: A MARKER OF
DISEASE ACTIVITY OR REGULATOR OF INFLAMMATION AND PAIN?
Y. Savitskaya, C. Duarte, N. Marin, R. Tellez, A. Alfaro, F. Cruz,
A. Almazan, A. Almazan, C. Ibarra. Natl. Inst. of Rehabilitation, Mexico,
Mexico
Purpose: Knee osteoarthritis (kOA) results, at least in part, from over-
loading and inﬂammation leading to cartilage degradation. Inﬂammatory
mediators such as bradykinin, histamine, prostaglandins, lactic acid,
substance P, and calcitonin generelated peptide are released into the joint.
Innate immune system activation, best documented in responses to
pathogens, likely plays a role in induction of inﬂammatory mediators in
kOA. Angiotensin-converting enzyme (ACE) plays an important role in
a number of inﬂammatory and immune related disorders. The aim of our
work was to study the expression of natural antibodies against ACE (ACE-
NA) in the peripheral blood sera of kOA patients and found a correlation
between serum ACE-NA level and other markers.
Methods: Sera were obtained from 57 patients with primary kOA fulﬁlling
the American College of Rheumatology criteria and 57 ethnically matched
healthy controls. All kOA patients had involvement of the knee joint with
typical radiographic changes graded Kellgren & Lawrence classiﬁcation.
The presence of ACE-NA was examined by a novel ELISA. Afﬁnity chro-
matography yielded ACE-NA (revealed upon Ion-exchange Chromatog-
raphy on QAE Sephadex) from both kOA patients and healthy individuals.
Expression of cytokines was measured by Bio-Plex Human Cytokine Assay
(Bio-Rad Inc, Hercules, CA, USA).
Results: ACE antibodies (IgM, IgG, IgA), reacting with ACE tested, were
present in the sera of kOA patients as well as in the sera of normal indi-
viduals. Afﬁnity chromatography yielded three (IgM, IgG, IgA) isotypes of
ACE-speciﬁc NA from the both kOA patients and healthy individuals.
Puriﬁed ACE-NA displayed the expected characteristics and was func-
tionally fully active. No statistically signiﬁcant differences were found
between ACE-IgG and ACE-IgA for kOA patients and healthy individuals.
The level of ACE-IgM in the sera from the kOA patients was signiﬁcantly
higher than those from the control group (P<0.005). ACE-IgM was
expressed at higher levels in kOA than in other OA. No correlation was
found between serum ACE-IgM level and patient's age and body mass
index. There was a positive correlation between serum ACE-IgM level and
expression of pain-associated molecules such as inducible nitric oxide
synthase (r¼0.652; P<0.01), IL-6 (r¼0.815; P<0.05) and proinﬂammatory
cytokine as such IL-1 (r¼0.789; P<0.01).
Conclusions: We ﬁrst identiﬁed ACE-NA in the sera of kOA patients. The
ACE-IgM test gives signiﬁcant information about kOA patients. Serum ACE-
IgM is a good discriminator between kOA patients versus patients with
other OA and healthy people. Serum ACE-IgM level may help to classify OA
patients. We shown that their could be used a speciﬁc marker for diagnosis
and prognosis of primary kOA. Renewed interest in ACE antibodies opens
up a new area for kOA diagnostics and therapeutics.
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MACROPHAGES ARE MODULATED BY FACTORS SECRETED BY
ADIPOCYTES
I. Klein-Wieringa, S. Andersen, J. Kwekkeboom, B. de Lange,
M. Kloppenburg, R. Toes, A. Ioan-Facsinay. Leiden Univ. Med. Ctr., Leiden,
Netherlands
Purpose: Obesity has been associated with development and progression
of osteoarthritis. Although the biological mechanisms underlying this
association are unknown, several studies have indicated that adipose
tissue secretes a large variety of soluble factors that can inﬂuence whole-
body metabolism. We have recently shown that the infrapatellar fat pad
(IFP), an adipose tissue organ in the knee joint, is a source of inﬂammatory
mediators that could inﬂuence joint pathology. Moreover, we identiﬁed
obesity-related changes in cytokine release by IFP. Both adipocytes and
immune cells present in IFP could constitute the source of these inﬂam-
matory mediators. Among IFP-inﬁltrating immune cells, macrophages are
